FCER2 and allergic bronchopulmonary aspergillosis: Recently, in 2000 and 2004, increased sensitivity to in vitro IL-4 stimulation as measured by enhanced expression of the low-affinity IgE receptor (CD23) on B cells was observed in ABPA patients [32, 33].